Periventricular remyelination failure in multiple sclerosis: a substrate for neurodegeneration
Mattéo Tonietto(Centre National de la Recherche Scientifique), Bruno Stankoff(Pitié-Salpêtrière Hospital), Michel Bottlaender(Centre National de la Recherche Scientifique), Émilie Poirion(Inserm), Caroline Papeix(Sorbonne Université), Vito A. G. Ricigliano(Inserm), Andrea Lazzarotto(Centre National de la Recherche Scientifique), Benedetta Bodini(Inserm)
Cited by 61
Related Papers
Myelin-oligodendrocyte glycoprotein antibody-associated disease
|The Lancet Neurology|2021|518
A “Candidate-Interactome” Aggregate Analysis of Genome-Wide Association Data in Multiple Sclerosis
|PLoS ONE|2013|511
Brain atrophy and lesion load predict long term disability in multiple sclerosis
|Journal of Neurology Neurosurgery & Psychiatry|2013|327
Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria
|The Lancet Neurology|2025|314
Clinical Relevance of Brain Volume Measures in Multiple Sclerosis
|CNS Drugs|2014|293